Antithrombin III (Octapharma Ab)

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameAntithrombin III (Octapharma Ab)
Drug Alias NameAtenativ
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor X inhibitorsThrombin inhibitorsAntithrombin-III replacements
TargetsProthrombinCoagulation factor X
Therapy Area/IndicationsAntithrombin III Deficiency
Global Approved IndicationsAntithrombin III Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2007/12/20
Country/TerritoryCzechiaArmeniaCanada +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesOctapharmaOctapharma Ab
Inactive CompaniesN/A
Active IndicationsAntithrombin III Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG